Rithika Rajendran

Veterans Health Administration — United States

Medicine · Health Sciences

3h-index28citations12works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(9), HER2/EGFR in Cancer Research(5), Prostate Cancer Diagnosis and Treatment(4), Radiopharmaceutical Chemistry and Applications(2), Radiomics and Machine Learning in Medical Imaging(2)

Publications12 total

Historical Perspective of HER2 Testing and Treatment in Prostate Cancer
Current Oncology·2026Open Access
Survival and response rates of histone deacetylase inhibitors in peripheral T-cell lymphoma: A comprehensive systematic review and meta-analysis of 67 studies.
Blood·2025Open Access
Clinical response to novel combination of trastuzumab deruxtecan and abiraterone in HER2-expressing metastatic castration-resistant prostate cancer
The Oncologist·2025Open Access
Investigating Intensity and Percentage of p53 Nuclear Expression in Prostate Cancer: Findings from a Cohort of U.S. Military Veterans
Cancers·2025· 3 citedOpen Access
Developing a deep learning algorithm for automated p53 immunohistochemistry digital image analysis in prostate cancer.
Journal of Clinical Oncology·2025
Response of Human Epidermal Growth Factor Receptor 2–Expressing Prostate Cancer to Trastuzumab Deruxtecan
Annals of Internal Medicine·2024· 5 cited
Prevalence of HER3 expression in prostate adenocarcinoma and its clinicopathological characteristics.
Journal of Clinical Oncology·2024· 1 cited
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing
Current Oncology·2024· 4 citedOpen Access
The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma
Annals of Diagnostic Pathology·2023· 13 citedOpen Access
RIPK2 as a prognostic biomarker and predictor of aggressive prostate cancer.
Journal of Clinical Oncology·2023· 1 cited
The prevalence and clinical significance of HER2 overexpression in prostate adenocarcinoma.
Journal of Clinical Oncology·2023
The Prevalence and Clinical Significance of Her2 Expression in Prostate Adenocarcinoma
SSRN Electronic Journal·2023· 1 citedOpen Access

Frequent Co-authors

Victor E. Nava(11), Minish Jain(10), Fayez Estephan(8), Coen J. Lap(8), Guoqing Diao(7), Ramesh Subrahmanyam(6), Shanshan Liu(5), Alexandra Zara Rozalen(4), Jeff Banagan(3), Martha Antonio(2), Steven H. Krasnow(2), José Manuel Martín(2), Angela M. Heiraty(2), William C. Hahn(2), Antonio Martha(2), Morgan Byrne(2), Karan Jatwani(2), Aarati Poudel(2), Manisha Uppal(1), Antonio Escobar(1)